CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study

BACKGROUND: C-C chemokine receptor 5 (CCR5) has recently been recognized as an underlying therapeutic target for various malignancies. However, the association of CCR5 with prognosis in the head and neck squamous cell carcinoma (HNSC) patients and tumor-infiltrating lymphocytes (TILs) is unclear. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunhong, Chen, Shanlin, Liu, Chuanyu, Mo, Chune, Gong, Weiwei, Hu, Jiahua, He, Min, Xie, Lei, Hou, Xianliang, Tang, Jianhong, Ou, Minglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513963/
https://www.ncbi.nlm.nih.gov/pubmed/36167571
http://dx.doi.org/10.1186/s41065-022-00251-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513963/
https://www.ncbi.nlm.nih.gov/pubmed/36167571
http://dx.doi.org/10.1186/s41065-022-00251-y

Ejemplares similares